Marsh & McLennan Companies, Inc. (MRSH) Market Cap & Valuation Ratios
Marsh & McLennan Companies, Inc. (MRSH) has a market cap of $93.9B, a trailing P/E of 23.6 and a price-to-sales ratio of 3.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
MRSHMarsh & McLennan Companies, Inc.Follow MRSH — free
—
Price chart with a free account
- Market cap
- 93.9B
- P/E TTM
- 23.6
- Dividend yield
- 1.9%
- 52-week
- —
- Next earnings
- 27 Jan, in 95 days
Peers
insurance brokers · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| MRSH | 94 | 23.6 | 4.0 | 16.1 | — | +8% | 21% | 14% |
| AJG | 69 | 44.5 | 5.1 | — | — | +26% | — | — |
| AON | 64 | 16.7 | 4.4 | 14.1 | — | +5% | 26% | 15% |
| WTW | 30 | 20.1 | 3.5 | 13.1 | — | +3% | 22% | 15% |
| BRO | 24 | 23.0 | 4.6 | — | — | +34% | — | — |
| ERIE | 12 | — | 2.8 | 14.4 | — | +4% | 18% | 29% |
| HGTY | 5.4 | — | 3.7 | — | — | +5% | — | — |
| BWIN | 4.5 | — | 3.9 | 97.5 | — | +19% | -7% | -5% |
| ARX | 4.3 | — | 2.5 | — | — | +55% | — | — |
| CRVL | 4.2 | 37.3 | 4.0 | — | — | +7% | — | — |
| NP | 3.9 | 91.5 | 20.8 | 57.7 | — | +34% | 41% | — |
| Median of these 10 | 30.1 | 4.0 | 14.4 | — | +13% | 22% | 15% |
P/E 23.6 vs. a peer median of 30.1; EV/Sales 4.0 vs. 4.0. MRSH's own P/E sits at the 23rd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesERIE and HGTY and BWIN and ARX have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Marsh & McLennan Companies, Inc. — questions
- What is Marsh & McLennan Companies, Inc.'s market cap?
- $93.9B.
- What is Marsh & McLennan Companies, Inc.'s P/E ratio?
- 23.6 on trailing twelve-month earnings to 2026-09-30.
- What is Marsh & McLennan Companies, Inc.'s price-to-sales ratio?
- 3.3.
Every figure on this page comes from Marsh & McLennan Companies, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.